Evonik Venture Capital

Evonik Venture Capital (EVC) is the corporate venture arm of Evonik Industries AG, a global leader in specialty chemicals headquartered in Hanau, Germany. Established to identify and invest in innovative technologies and business models, EVC plays a crucial role in Evonik's long-term growth strategy. Its mandate extends beyond purely financial returns, focusing on strategic alignment with Evonik's core businesses and exploring new growth areas that complement the parent company's extensive portfolio. EVC seeks to foster collaborations between its portfolio companies and Evonik's business units, providing not only capital but also access to industry expertise, global networks, and market access.

EVC primarily targets early-stage companies, typically from seed to Series B rounds, that are developing disruptive solutions in areas strategic to Evonik. These key investment themes include sustainable solutions, advanced materials, industrial biotechnology, digitalization, and health & nutrition. The firm looks for startups that can contribute to a circular economy, enhance resource efficiency, or introduce novel chemical processes and products. EVC emphasizes a hands-on approach, often taking board observer or board seats to actively support the development and scaling of its portfolio companies.

Evonik Venture Capital has demonstrated a significant commitment to corporate venturing. Initially launching with a €100 million fund in 2012, the company doubled its total venture capital commitment to €250 million in 2018, underscoring its long-term vision for innovation. Typical initial investments range from €1 million to €10 million, with the potential for follow-on investments. Their portfolio includes over 20 active investments across various stages and geographies, showcasing their broad reach and strategic impact within the specialty chemicals ecosystem.